Researchers take a step towards large-scale medical genetics research in psychiatry
Two reports published in Biological Psychiatry demonstrate an approach to use electronic health records to more accurately investigate neuropsychiatric symptoms. It is hoped that this research will help inspire more research that could lead to large-scale medical genetics research in psychiatry.
Researchers at Massachusetts General Hospital and Harvard Medical School have developed a new method to extract symptom information from doctors’ notes, allowing them to capture the complexity of psychiatric disorders that is missed by traditional sources of clinical data. The study, published in Biological Psychiatry, was led by co-senior authors Dr Tianxi Caiand Dr Roy Perlis.
A second study published in Biological Psychiatry, also led by Dr Perlis, applied the new method in a proof-of-concept study to identify genes associated with psychiatric symptoms.
‘Many efforts to use clinical documentation in electronic health records for research aim to identify individual symptoms, like the presence or absence of psychosis,’ said Dr Thomas McCoy Jr, co-first author with Dr Sheng Yu, But this approach misses the complex overlap of symptoms between different mental disorders. ‘My co-authors and I developed a method that instead captures symptom dimensions, or sets of symptoms, informed by the National Institute of Mental Health Research Domain Criteria,’ continued Dr McCoy.
The method has been designed to extract the relevant symptoms from the wealth of information in the detailed narrative notes taken by clinicians in patients’ electronic health records. Dr McCoy and colleagues used the method to characterise 3,619 adults with psychiatric hospitalisations across a range of disorders, including schizophrenia, anxiety, major depressive disorder, and posttraumatic stress disorder.
Characterising the patients based on symptom dimensions could predict the length of hospital stay and time to hospital readmission better than the use of more structured data alone, such as health billing information that is based on the categorisation of disorders. The symptom dimensions were also associated with scoring of notes by expert clinicians and with neurocognitive testing, validating the results.
The idea of symptom domains rather than disease categories also extends to the neurobiology of mental illness. ‘The recognition that the genetic basis of psychiatric illness crosses traditional boundaries has encouraged efforts to understand psychopathology according to dimensions, rather than simply presence or absence of symptoms,’ said Dr McCoy.
In the second study, Dr McCoy and colleagues demonstrated the application of this new method to examine the association between symptom dimensions and common genetic variation in psychiatric disease. They compared the information on the symptom dimensions extracted from the narrative hospital discharge notes of 4,687 adults with the patients’ genomic information. The researchers identified four areas of interest, or loci, in the genome, highlighting two genes which have not previously been identified with existing methods.
‘The ability to combine large DNA data sets with meaningful psychiatric information from the electronic health record is an important step in facilitating large-scale medical genetics research in psychiatry,’ said John Krystal, editor of Biological Psychiatry.
The authors suggest that the method offers a new approach to understand brain function in mental illness. Other researchers can apply the method to different sets of patients with hospital-linked genomic records, and identification of the same loci would strengthen the support for their role in psychiatric symptoms.
‘We are making the scoring software freely available and hope this work will enable transdiagnostic dimensional phenotypes to be used in efforts to achieve precision psychiatry,’ said Dr McCoy.